美国临床分离株（2019 - 2021年）中对常见口服抗生素的高不敏感性率
High Rates of Nonsusceptibility to Common Oral Antibiotics in Clinical Isolates From the United States (2019-2021).
作者信息
Deshpande Lalitagauri M, Huband Michael D, Charbon Sarah, Castanheira Mariana, Mendes Rodrigo E
机构信息
Element Iowa City (JMI Laboratories), North Liberty, Iowa, USA.
出版信息
Open Forum Infect Dis. 2024 Aug 22;11(9):ofae470. doi: 10.1093/ofid/ofae470. eCollection 2024 Sep.
Abstract
isolates from the United States (n = 1038; 2019-2021) were susceptible to omadacycline (99.8%), levofloxacin (99.7%), and ceftriaxone (98.1%), whereas doxycycline (80.2%), oral penicillin (63.5%), cefpodoxime (76.8%), and azithromycin (54.4%) activity was limited. (M) did not affect omadacycline activity but altered activity of older tetracyclines including doxycycline, suggesting omadacycline is an important option for treatment of community-acquired bacterial pneumonia.
摘要
来自美国的分离株（n = 1038；2019 - 2021年）对奥马环素（99.8%）、左氧氟沙星（99.7%）和头孢曲松（98.1%）敏感，而多西环素（80.2%）、口服青霉素（63.5%）、头孢泊肟（76.8%）和阿奇霉素（54.4%）的活性有限。（M）不影响奥马环素的活性，但改变了包括多西环素在内的 older tetracyclines 的活性，提示奥马环素是治疗社区获得性细菌性肺炎的重要选择。 （注：原文中“older tetracyclines”表述有误，推测可能是“老一代四环素类药物”，这里按原文翻译）
相似文献
1
High Rates of Nonsusceptibility to Common Oral Antibiotics in Clinical Isolates From the United States (2019-2021).美国临床分离株（2019 - 2021年）中对常见口服抗生素的高不敏感性率
Open Forum Infect Dis. 2024 Aug 22;11(9):ofae470. doi: 10.1093/ofid/ofae470. eCollection 2024 Sep.
2
Surveillance of omadacycline activity tested against clinical isolates from the United States and Europe: Results from the SENTRY Antimicrobial Surveillance Programme, 2017.对来自美国和欧洲的临床分离株进行奥马环素活性检测的监测：来自 SENTRY 抗菌监测计划的 2017 年结果。
J Glob Antimicrob Resist. 2019 Dec;19:56-63. doi: 10.1016/j.jgar.2019.02.017. Epub 2019 Feb 27.
3
Surveillance of Omadacycline Activity Tested against Clinical Isolates from the United States and Europe: Report from the SENTRY Antimicrobial Surveillance Program, 2016 to 2018.对来自美国和欧洲的临床分离株进行奥马环素活性测试的监测：来自 SENTRY 抗菌监测计划的报告，2016 年至 2018 年。
Antimicrob Agents Chemother. 2020 Apr 21;64(5). doi: 10.1128/AAC.02488-19.
4
Activity of omadacycline tested against Streptococcus pneumoniae from a global surveillance program (2014).2014年全球监测项目中奥马环素对肺炎链球菌的活性检测
Diagn Microbiol Infect Dis. 2018 Feb;90(2):143-147. doi: 10.1016/j.diagmicrobio.2017.10.010. Epub 2017 Oct 19.
5
Cost-Saving Opportunities with an Oral and Intravenous Once-Daily Aminomethylcycline Antibiotic for Hospitalized Patients with Community-Acquired Bacterial Pneumonia: Findings from Decision-Analytic Models.口服和静脉注射每日一次氨甲基环素抗生素用于社区获得性细菌性肺炎住院患者的成本节约机会：决策分析模型的结果
Am Health Drug Benefits. 2019 Jun-Jul;12(4):168-176.
6
Antimicrobial Activity of Omadacycline Tested against Clinical Bacterial Isolates from Hospitals in Mainland China, Hong Kong, and Taiwan: Results from the SENTRY Antimicrobial Surveillance Program (2013 to 2016).奥马环素对中国大陆、香港和台湾地区医院临床分离细菌的抗菌活性研究：SENTRY 抗菌监测计划（2013 年至 2016 年）的结果。
Antimicrob Agents Chemother. 2019 Feb 26;63(3). doi: 10.1128/AAC.02262-18. Print 2019 Mar.
7
The pharmacokinetic evaluation of omadacycline (Oral Only Dosing Regimen) for the treatment of Community-Acquired Bacterial Pneumonia (CABP).奥马环素（仅口服给药方案）治疗社区获得性细菌性肺炎（CABP）的药代动力学评价。
Expert Opin Drug Metab Toxicol. 2023 Sep;19(9):569-576. doi: 10.1080/17425255.2023.2261376. Epub 2023 Oct 12.
8
In vitro and in vivo antibacterial activities of omadacycline, a novel aminomethylcycline.奥马环素的体外和体内抗菌活性，一种新型的氨甲基环素。
Antimicrob Agents Chemother. 2014;58(2):1127-35. doi: 10.1128/AAC.01242-13. Epub 2013 Dec 2.
9
Activity of Omadacycline against .奥马环素对. 的活性。
Antimicrob Agents Chemother. 2019 Jan 29;63(2). doi: 10.1128/AAC.01907-18. Print 2019 Feb.
10
[Antimicrobial susceptibility of community-acquired respiratory tract pathogens isolated from adults in China during 2009 and 2010].[2009年至2010年期间从中国成年人中分离出的社区获得性呼吸道病原体的抗菌药敏性]
Zhonghua Jie He He Hu Xi Za Zhi. 2012 Feb;35(2):113-9.
引用本文的文献
1
Re-evaluation of penicillin and ceftriaxone MIC results to predict susceptibility to the oral cephalosporin, cefpodoxime, in clinical isolates from the United States according to CLSI guidelines (2019-2021).根据美国临床和实验室标准协会（CLSI）指南（2019 - 2021年）重新评估青霉素和头孢曲松的最低抑菌浓度（MIC）结果，以预测美国临床分离株对口服头孢菌素头孢泊肟的敏感性。
J Clin Microbiol. 2025 Jun 24:e0002725. doi: 10.1128/jcm.00027-25.
本文引用的文献
1
A Multicenter Evaluation of Trends in Antimicrobial Resistance Among Isolates From Adults in the United States.美国成年人分离株中抗菌药物耐药性趋势的多中心评估
Open Forum Infect Dis. 2022 Sep 2;9(9):ofac420. doi: 10.1093/ofid/ofac420. eCollection 2022 Sep.
2
Emergence of a multidrug-resistant and virulent Streptococcus pneumoniae lineage mediates serotype replacement after PCV13: an international whole-genome sequencing study.PCV13 接种后，一种具有多重耐药性和强毒力的肺炎链球菌谱系的出现介导了血清型转变：一项国际全基因组测序研究。
Lancet Microbe. 2022 Oct;3(10):e735-e743. doi: 10.1016/S2666-5247(22)00158-6. Epub 2022 Aug 16.
3
Efficacy of Doxycycline for Mild-to-Moderate Community-Acquired Pneumonia in Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.多西环素治疗成人轻至中度社区获得性肺炎的疗效：一项随机对照试验的系统评价和荟萃分析
Clin Infect Dis. 2023 Feb 18;76(4):683-691. doi: 10.1093/cid/ciac615.
4
Comprehensive value assessments for new pediatric pneumococcal conjugate vaccines.新型儿童肺炎球菌结合疫苗的综合价值评估
J Med Econ. 2021 Jan-Dec;24(1):1083-1086. doi: 10.1080/13696998.2021.1970974.
5
Streptococcus pneumoniae serotype distribution and antimicrobial nonsusceptibility trends among adults with pneumonia in the United States, 2009‒2017.2009 年至 2017 年美国肺炎成人患者中肺炎链球菌血清型分布及抗菌药物非敏感性趋势。
J Infect. 2020 Oct;81(4):557-566. doi: 10.1016/j.jinf.2020.07.035. Epub 2020 Jul 31.
6
Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America.成人社区获得性肺炎诊断和治疗。美国胸科学会和美国传染病学会的官方临床实践指南。
Am J Respir Crit Care Med. 2019 Oct 1;200(7):e45-e67. doi: 10.1164/rccm.201908-1581ST.
7
In vitro and in vivo antibacterial activities of omadacycline, a novel aminomethylcycline.奥马环素的体外和体内抗菌活性，一种新型的氨甲基环素。
Antimicrob Agents Chemother. 2014;58(2):1127-35. doi: 10.1128/AAC.01242-13. Epub 2013 Dec 2.
8
Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance.四环素类抗生素：作用机制、应用、分子生物学及细菌耐药性流行病学
Microbiol Mol Biol Rev. 2001 Jun;65(2):232-60 ; second page, table of contents. doi: 10.1128/MMBR.65.2.232-260.2001.
9
Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States.美国流感嗜血杆菌、卡他莫拉菌和肺炎链球菌呼吸道分离株中的抗菌药物耐药性
Antimicrob Agents Chemother. 1990 Nov;34(11):2075-80. doi: 10.1128/AAC.34.11.2075.
10
Antimicrobial resistance of Streptococcus pneumoniae in the United States, 1979-1987. The Pneumococcal Surveillance Working Group.1979 - 1987年美国肺炎链球菌的抗菌药物耐药性。肺炎球菌监测工作组。
J Infect Dis. 1991 Jun;163(6):1273-8. doi: 10.1093/infdis/163.6.1273.
Zotero 插件